A Circuit-Based Information Approach to Substance Abuse Research.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Lovinger DM;Lovinger DM; Gremel CM; Gremel CM
  • Source:
    Trends in neurosciences [Trends Neurosci] 2021 Feb; Vol. 44 (2), pp. 122-135. Date of Electronic Publication: 2020 Nov 06.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Applied Science Publishing Country of Publication: England NLM ID: 7808616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-108X (Electronic) Linking ISSN: 01662236 NLM ISO Abbreviation: Trends Neurosci Subsets: MEDLINE
    • Publication Information:
      Publication: Barking : Elsevier Applied Science Publishing
      Original Publication: Amsterdam, New York, Elsevier/North-Holland Biomedical Press.
    • Subject Terms:
    • Abstract:
      Recent animal research on substance-use disorders (SUDs) has emphasized learning models and the identification of 'addiction-prone' animals. Meanwhile, basic neuroscientific research has elucidated molecular, cellular, and circuit functions with increasing sophistication. However, SUD-related research is hampered by continued arguments over which animal models are more 'addiction like', as well as the facile assignment of behaviors to a given brain region and vice versa. We argue that SUD-related research would benefit from a 'bottom-up' approach including: (i) the characterization of different brain circuits to understand their normal function as well as how they respond to drugs and contribute to SUDs; and (ii) a focus on the use patterns and neurobiological effects of different substances to understand the range of critical SUD-related in vivo phenotypes.
      (Published by Elsevier Ltd.)
    • References:
      Neuropsychopharmacology. 2014 Feb;39(3):579-94. (PMID: 23995582)
      Front Syst Neurosci. 2015 Oct 08;9:140. (PMID: 26500513)
      Neuropsychopharmacology. 2011 Nov;36(12):2513-28. (PMID: 21796110)
      Neuron. 2014 Jan 8;81(1):153-64. (PMID: 24411738)
      Neuropsychopharmacology. 2017 Jan;42(1):369-370. (PMID: 27909323)
      Trends Neurosci. 1989 Oct;12(10):366-75. (PMID: 2479133)
      Addict Biol. 2012 Jan;17(1):13-32. (PMID: 21955048)
      Nat Neurosci. 2018 Nov;21(11):1520-1529. (PMID: 30323276)
      Neurosci Biobehav Rev. 2015 Jul;54:89-107. (PMID: 25616182)
      Neuron. 2018 Oct 24;100(2):436-452. (PMID: 30359607)
      Annu Rev Neurosci. 2004;27:1-28. (PMID: 15217324)
      Neuropsychopharmacology. 2020 Apr;45(5):720-735. (PMID: 31905368)
      Nat Rev Neurosci. 2020 May;21(5):247-263. (PMID: 32231315)
      Cell Rep. 2018 Oct 9;25(2):487-500.e6. (PMID: 30304687)
      Neuron. 2016 Jun 15;90(6):1312-1324. (PMID: 27238866)
      Neuron. 2018 Apr 18;98(2):366-379.e4. (PMID: 29628187)
      J Neurosci. 2019 Feb 27;39(9):1744-1754. (PMID: 30617206)
      Neurosci Biobehav Rev. 2020 Jan;108:435-444. (PMID: 31756346)
      Annu Rev Neurosci. 2011;34:441-66. (PMID: 21469956)
      Curr Opin Neurobiol. 2018 Jun;50:171-178. (PMID: 29627516)
      Biochim Biophys Acta Gen Subj. 2018 Apr;1862(4):800-807. (PMID: 29273222)
      Science. 2018 Jun 22;360(6395):1321-1326. (PMID: 29930131)
      Neuron. 2015 Apr 22;86(2):501-13. (PMID: 25843402)
      Dev Cogn Neurosci. 2015 Dec;16:183-190. (PMID: 25575668)
      Annu Rev Psychol. 2016;67:23-50. (PMID: 26253543)
      Curr Opin Neurobiol. 2015 Jun;32:53-9. (PMID: 25528614)
      Biol Psychiatry. 2017 Dec 1;82(11):847-856. (PMID: 28673442)
      J Neurosci. 2006 Aug 9;26(32):8368-76. (PMID: 16899732)
      J Stud Alcohol Drugs. 2016 Sep;77(5):696-9. (PMID: 27588527)
      Alcohol. 2004 Apr;32(3):203-12. (PMID: 15282114)
      Nat Neurosci. 2015 Feb;18(2):170-81. (PMID: 25622573)
      Addiction. 2000 Aug;95 Suppl 2:S91-117. (PMID: 11002906)
      Biol Psychiatry. 2019 Dec 1;86(11):848-856. (PMID: 31326085)
      Neuron. 2015 May 6;86(3):800-12. (PMID: 25892304)
      Int Rev Neurobiol. 2016;126:157-77. (PMID: 27055614)
      Annu Rev Neurosci. 2019 Jul 8;42:459-483. (PMID: 31018098)
      Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt A):22-32. (PMID: 28663112)
      J Neurosci. 2013 Apr 24;33(17):7583-94. (PMID: 23616563)
      Nat Neurosci. 2016 Apr;19(4):554-6. (PMID: 26950004)
      Trends Neurosci. 2003 Apr;26(4):184-92. (PMID: 12689769)
      Neurosci Biobehav Rev. 2020 Mar;110:3-27. (PMID: 30179633)
      Alcohol Clin Exp Res. 2020 Apr;44(4):880-891. (PMID: 32020644)
      Mol Pharmacol. 1988 Nov;34(5):605-13. (PMID: 2848184)
      PLoS One. 2010 Jul 28;5(7):e11592. (PMID: 20676364)
      Neuron. 1996 Feb;16(2):237-40. (PMID: 8789938)
      J Neurosci. 2016 Nov 9;36(45):11489-11495. (PMID: 27911752)
      Genes Brain Behav. 2017 Jan;16(1):56-70. (PMID: 27860248)
      Alcohol Clin Exp Res. 2008 Oct;32(10):1816-23. (PMID: 18671810)
      Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3169-79. (PMID: 18640918)
      Nat Neurosci. 2015 Sep;18(9):1202-12. (PMID: 26308981)
      J Neurosci. 2007 Jan 24;27(4):791-5. (PMID: 17251418)
      Pharmacol Biochem Behav. 2018 Jan;164:4-21. (PMID: 28942119)
      J Neurosci. 2016 May 18;36(20):5556-71. (PMID: 27194335)
      Science. 2018 Nov 16;362(6416):. (PMID: 30385464)
      Neurosci Biobehav Rev. 2019 Nov;106:91-101. (PMID: 30309630)
      Trends Neurosci. 1990 Jul;13(7):266-71. (PMID: 1695401)
      Pharmacol Biochem Behav. 2018 Oct;173:65-73. (PMID: 30056175)
      Elife. 2016 Nov 28;5:. (PMID: 27892854)
      Eur Neuropsychopharmacol. 2016 May;26(5):856-68. (PMID: 26774279)
      Front Cell Neurosci. 2016 Nov 11;10:264. (PMID: 27891077)
      Q J Exp Psychol B. 2002 Oct;55(4):331-48. (PMID: 12350285)
      Curr Opin Neurobiol. 2013 Aug;23(4):559-63. (PMID: 23628232)
      J Neurosci. 2000 Mar 15;20(6):2369-82. (PMID: 10704511)
      Nat Commun. 2018 Jan 15;9(1):211. (PMID: 29335427)
      Brain Res Rev. 2007 Nov;56(1):27-78. (PMID: 17574681)
      Neuropharmacology. 1998 Apr-May;37(4-5):407-19. (PMID: 9704982)
      J Neural Transm (Vienna). 2018 Mar;125(3):531-545. (PMID: 28766041)
      Nat Rev Neurosci. 2006 Jun;7(6):464-76. (PMID: 16715055)
      Biol Psychiatry. 2016 Jan 1;79(1):39-46. (PMID: 25747744)
      Genes Brain Behav. 2010 Oct;9(7):768-76. (PMID: 20608999)
      Nature. 2015 May 7;521(7550):85-9. (PMID: 25739505)
      J Neurochem. 2020 Dec;155(5):475-493. (PMID: 32356315)
      Nat Neurosci. 2013 Jul;16(7):966-73. (PMID: 23708143)
      Learn Mem. 2016 Sep 15;23(10):515-33. (PMID: 27634143)
      J Neurosci. 1997 Mar 15;17(6):2143-67. (PMID: 9045740)
      Nat Neurosci. 2005 Nov;8(11):1481-9. (PMID: 16251991)
      Science. 2004 Aug 13;305(5686):1014-7. (PMID: 15310906)
      Curr Opin Neurobiol. 2008 Apr;18(2):185-96. (PMID: 18708140)
      J Neurosci. 2002 Sep 15;22(18):8117-32. (PMID: 12223566)
      Nat Neurosci. 2012 Jan 08;15(2):284-93. (PMID: 22231426)
      Ann N Y Acad Sci. 2013 Apr;1282:12-24. (PMID: 23126270)
      Prog Brain Res. 2012;196:235-63. (PMID: 22341329)
      J Neurosci. 2016 May 18;36(20):5472-88. (PMID: 27194328)
      Curr Opin Neurobiol. 2019 Dec;59:128-136. (PMID: 31255844)
      Brain Res. 2019 Jun 15;1713:70-79. (PMID: 30300636)
      Curr Opin Neurobiol. 2015 Aug;33:188-96. (PMID: 26189204)
      Nature. 2016 Nov 10;539(7628):289-293. (PMID: 27652894)
      J Exp Psychol Anim Behav Process. 2007 Jan;33(1):1-11. (PMID: 17227190)
      Elife. 2019 Dec 11;8:. (PMID: 31820733)
      ACS Chem Neurosci. 2015 Jan 21;6(1):84-93. (PMID: 25565280)
      PLoS One. 2015 Apr 01;10(4):e0123381. (PMID: 25830919)
      Lancet Psychiatry. 2016 Aug;3(8):760-773. (PMID: 27475769)
      Alcohol. 1990 May-Jun;7(3):221-5. (PMID: 2184835)
      Behav Brain Res. 2011 Mar 17;218(1):152-7. (PMID: 20974184)
      Front Neuroinform. 2020 Jan 22;13:78. (PMID: 32038217)
      Neuron. 2016 Feb 17;89(4):683-94. (PMID: 26889809)
      Annu Rev Neurosci. 2000;23:155-84. (PMID: 10845062)
      J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):249-66. (PMID: 9706533)
      Front Syst Neurosci. 2014 Jan 30;8:5. (PMID: 24523677)
      Genes Brain Behav. 2017 Jan;16(1):71-85. (PMID: 27457495)
      Neurochem Res. 1996 Nov;21(11):1437-54. (PMID: 8947934)
      Nat Neurosci. 2014 Sep;17(9):1276-85. (PMID: 25086607)
      Am J Psychiatry. 2016 Nov 1;173(11):1083-1093. (PMID: 27609244)
      Nature. 2013 Aug 22;500(7463):472-476. (PMID: 23877069)
      Front Behav Neurosci. 2013 Dec 06;7:190. (PMID: 24367307)
      PLoS One. 2012;7(8):e42886. (PMID: 22870342)
      Neuroscience. 2015 Aug 20;301:529-41. (PMID: 26116518)
      Nature. 1990 Aug 9;346(6284):561-4. (PMID: 2165569)
      Nat Biomed Eng. 2019 May;3(5):392-401. (PMID: 30992553)
      Pharmacopsychiatry. 2018 Jul;51(4):136-143. (PMID: 28950395)
      Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):377-85. (PMID: 27338962)
    • Grant Information:
      R01 AA026077 United States AA NIAAA NIH HHS; ZIA AA000416 United States ImNIH Intramural NIH HHS
    • Contributed Indexing:
      Keywords: basal ganglia; cortex; drug of abuse; learning; striatum
    • Publication Date:
      Date Created: 20201110 Date Completed: 20210818 Latest Revision: 20210818
    • Publication Date:
      20240105
    • Accession Number:
      PMC7856012
    • Accession Number:
      10.1016/j.tins.2020.10.005
    • Accession Number:
      33168235